These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 3108839

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Two patients with a fatal haemolytic-uremic syndrome after combination therapy including mitomycin C.
    Boven E, Pinedo HM.
    Neth J Med; 1983; 26(9):288. PubMed ID: 6419135
    [No Abstract] [Full Text] [Related]

  • 46. Mitomycin--C-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: cumulative toxicity of an old drug in a new era.
    El-Ghazal R, Podoltsev N, Marks P, Chu E, Saif MW.
    Clin Colorectal Cancer; 2011 Jun; 10(2):142-5. PubMed ID: 21859568
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Mitomycin-C induced hemolytic uremic syndrome: a case report and literature review.
    Wu DC, Liu JM, Chen YM, Yang S, Liu SM, Chen LT, Whang-Peng J.
    Jpn J Clin Oncol; 1997 Apr; 27(2):115-8. PubMed ID: 9152802
    [Abstract] [Full Text] [Related]

  • 49. Tacrolimus-induced hemolytic uremic syndrome and end-stage renal failure after liver transplantation.
    Rerolle JP, Akposso K, Lerolle N, Mougenot B, Ponnelle T, Rondeau E, Sraer JD.
    Clin Transplant; 2000 Jun; 14(3):262-5. PubMed ID: 10831087
    [Abstract] [Full Text] [Related]

  • 50. Treatment of mitomycin-C-associated hemolytic uremic syndrome with plasmapheresis.
    Poch E, Almirall J, Nicolas JM, Torras A, Revert L.
    Nephron; 1990 Jun; 55(1):89-90. PubMed ID: 2112726
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Cancer-associated hemolytic uremic syndrome: a possible role of mitomycin in relation to Shiga-like toxins.
    Acheson DW, Donohue-Rolfe A.
    J Clin Oncol; 1989 Dec; 7(12):1943. PubMed ID: 2511278
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Three cases of hemolytic uremic syndrome in ovarian cancer patients treated with combination gemcitabine and pegylated liposomal doxorubicin.
    Lewin SN, Mutch DG, Whitcomb BP, Liapis H, Herzog TJ.
    Gynecol Oncol; 2005 Apr; 97(1):228-33. PubMed ID: 15790464
    [Abstract] [Full Text] [Related]

  • 57. Haemolytic-uraemic syndrome associated with mitomycin-C treatment.
    Wils J, Grave W, van Breda Vriesman PJ.
    Neth J Med; 1987 Feb; 30(1-2):32-5. PubMed ID: 3108684
    [No Abstract] [Full Text] [Related]

  • 58. Mitomycin-C induced hemolytic uremic syndrome: a case report.
    Gundappa RK, Sud K, Kohli HS, Gupta KL, Joshi K, Sakhuja V.
    Ren Fail; 2002 May; 24(3):373-7. PubMed ID: 12166705
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.